These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38856962)

  • 1. Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness.
    Holcman K; Kostkiewicz M; Szot W; Ćmiel B; Mróz K; Stępień A; Graczyk K; Dziewięcka E; Karabinowska-Małocha A; Sachajko Z; Podolec P; Rubiś P
    Int J Cardiovasc Imaging; 2024 Aug; 40(8):1693-1703. PubMed ID: 38856962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right Ventricular Strain Improves the Echocardiographic Diagnosis and Risk Stratification of Transthyretin Cardiac Amyloidosis Among Other Phenotypes of Left Ventricular Hypertrophy.
    Ozbay B; Satyavolu BS; Rearick C; Soman P; Katz WE; Sezer A; Sade LE
    J Am Soc Echocardiogr; 2024 Oct; 37(10):947-959. PubMed ID: 38942217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine 4D Cardiac CT to Identify Concomitant Transthyretin Amyloid Cardiomyopathy in Older Adults with Severe Aortic Stenosis.
    Bernhard B; Leib Z; Dobner S; Demirel C; Caobelli F; Rominger A; Schütze J; Grogg H; Alwan L; Spano G; Boscolo Berto M; Lanz J; Pilgrim T; Windecker S; Stortecky S; Gräni C
    Radiology; 2023 Dec; 309(3):e230425. PubMed ID: 38085082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Right Ventricular Strain Measured by Two-Dimensional Echocardiography in the Diagnosis of Cardiac Amyloidosis.
    Moñivas Palomero V; Durante-Lopez A; Sanabria MT; Cubero JS; González-Mirelis J; Lopez-Ibor JV; Navarro Rico SM; Krsnik I; Dominguez F; Mingo AM; Hernandez-Perez FJ; Cavero G; Santos SM
    J Am Soc Echocardiogr; 2019 Jul; 32(7):845-853.e1. PubMed ID: 31078369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy.
    Rettl R; Wollenweber T; Duca F; Binder C; Cherouny B; Dachs TM; Camuz Ligios L; Schrutka L; Dalos D; Beitzke D; Loewe C; Badr Eslam R; Kastner J; Hacker M; Bonderman D
    Eur Heart J Cardiovasc Imaging; 2023 Jul; 24(8):1019-1030. PubMed ID: 36881774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
    Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
    Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of [
    Caobelli F; Gözlügöl N; Bakula A; Rominger A; Schepers R; Stortecky S; Hunziker Munsch L; Dobner S; Gräni C
    J Nucl Med; 2024 Jun; 65(6):944-951. PubMed ID: 38724281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease.
    Rausch K; Scalia GM; Sato K; Edwards N; Lam AK; Platts DG; Chan J
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):81-90. PubMed ID: 32728989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality.
    Sperry BW; Vranian MN; Tower-Rader A; Hachamovitch R; Hanna M; Brunken R; Phelan D; Cerqueira MD; Jaber WA
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):234-242. PubMed ID: 28917675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac amyloidosis is not a single disease: a multiparametric comparison between the light chain and transthyretin forms.
    Neculae G; Adam R; Jercan A; Bădeliță S; Tjahjadi C; Draghici M; Stan C; Bax JJ; Popescu BA; Marsan NA; Coriu D; Jurcuț R
    ESC Heart Fail; 2024 Oct; 11(5):2825-2834. PubMed ID: 38757395
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
    ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right ventricular involvement in transthyretin amyloidosis.
    Arvidsson S; Henein MY; Wikström G; Suhr OB; Lindqvist P
    Amyloid; 2018 Sep; 25(3):160-166. PubMed ID: 30193533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.
    Cuddy SA; Datar Y; Ovsak G; Saith S; Murphy SP; Bay CP; Haddad M; Lilleness B; Muralidhar V; Pipilas A; Vuong J; Guardino E; Maurer MS; Ruberg FL; Falk RH; Dorbala S
    Circ Cardiovasc Imaging; 2022 Nov; 15(11):e014645. PubMed ID: 36378779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac manifestations and prognostic implications of hereditary transthyretin amyloidosis associated with transthyretin Ala97Ser.
    Lai HJ; Huang KC; Liang YC; Chien KL; Lee MJ; Hsieh ST; Chao CC; Yang CC
    J Formos Med Assoc; 2020 Mar; 119(3):693-700. PubMed ID: 31521469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Castaño A; Narotsky DL; Hamid N; Khalique OK; Morgenstern R; DeLuca A; Rubin J; Chiuzan C; Nazif T; Vahl T; George I; Kodali S; Leon MB; Hahn R; Bokhari S; Maurer MS
    Eur Heart J; 2017 Oct; 38(38):2879-2887. PubMed ID: 29019612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis.
    Henein MY; Suhr OB; Arvidsson S; Pilebro B; Westermark P; Hörnsten R; Lindqvist P
    Amyloid; 2018 Mar; 25(1):46-53. PubMed ID: 29369708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders.
    López-Sainz Á; de Haro-Del Moral FJ; Dominguez F; Restrepo-Cordoba A; Amor-Salamanca A; Hernandez-Hernandez A; Ruiz-Guerrero L; Krsnik I; Cobo-Marcos M; Castro V; Toquero-Ramos J; Lara-Pezzi E; Fernandez-Lozano I; Alonso-Pulpon L; González-López E; Garcia-Pavia P
    Amyloid; 2019 Sep; 26(3):156-163. PubMed ID: 31210553
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative
    Vijayakumar S; Pabon AR; Clerc OF; Cuddy SAM; Gu Y; Watts C; Sullivan K; Auer B; Kijewski MF; DiCarli MF; Falk RH; Dorbala S
    J Nucl Cardiol; 2024 Sep; 39():102019. PubMed ID: 39128784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.